Stephen A. Sherwin, M.D.

Stephen A. Sherwin, M.D.

DirectoratNeurocrine Biosciences· In proxies 2023–2025

Stephen A. Sherwin, M.D. sits on 12 public boards.

Boards2

  • Neurocrine BiosciencesDirector · 26 yr on the boardIndependentAudit, Science and Medical Technology (Chair)—Paid as an executive
  • BiogenDirector · 15 yr on the boardIndependentAudit—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Neurocrine BiosciencesPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +22%
  2. BiogenPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Innovent Biologics, Inc.Public company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  4. Neurocrine Biosciences Inc.Public company · 27 yr
    • Director1999 – Present · 27 yrNo stock prices for these years
  5. Other Public Company Boards CurrentPublic company
    • Director? – PresentNo stock prices for these years
  6. Aduro BiotechPublic company
    • Director? – PresentNo stock prices for these years
  7. Aduro Biotech, BioPlus Acquisition CorporationPublic company
    • Director? – PresentNo stock prices for these years
  8. BioPlus Acquisition CorporationPublic company
    • Director? – PresentNo stock prices for these years
  9. Neon TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  10. Epiphany Technology Acquisition Corp.Public company · 1 yr
    • Director2022 – 2023 · 1 yrNo stock prices for these years
  11. Bios Special Acquisition CorporationPublic company · 2 yr
    • Director2021 – 2023 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?